Viking Therapeutics ( (VKTX) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Viking Therapeutics’ stock is on the rise, driven by promising Phase 1 results for its obesity treatment, VK2735. This has led to strong buy ratings and high price targets. Despite some concerns over increased share selling by company executives, the market remains optimistic about the potential of VK2735 in the healthcare sector.
More about Viking Therapeutics
YTD Price Performance: -2.65%
Average Trading Volume: 3,813,483
Technical Sentiment Signal: Buy
Current Market Cap: $4.5B
For further insights into VKTX stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.